Compare · BBH vs NHF
BBH vs NHF
Side-by-side comparison of VanEck Vectors Biotech ETF (BBH) and NexPoint Strategic Opportunities Fund (NHF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBH and NHF operate in n/a (n/a), so they compete in similar markets.
- NHF carries a market cap of $542.3M.
NexPoint Strategic Opportunities Fund
NexPoint Strategic Opportunities Fund is a closed ended balanced mutual fund launched by Highland Capital Management, L.P. It is managed by Nexpoint Advisors, L.P. The fund invests in the fixed income markets of the United States. It invests in companies across broadly diversified sectors to construct its portfolio. The fund typically invests in senior loans, secured and unsecured floating and fixed rate loans, bonds, debt obligations of stressed, distressed, and bankrupt issuers, mortgage-backed securities, asset-backed securities, and collateralized debt obligations with a primary focus on below investment grade debt and equity securities. It employs a quantitative analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the Dow Jones Credit Suisse Hedge Fund and the HFRX Global Hedge Fund. It was formerly known as NexPoint Credit Strategies Fund. NexPoint Strategic Opportunities Fund was formed on June 1, 2006 and is domiciled in the United States.
Latest BBH
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- VanEck Announces Year-End Distributions for VanEck Equity ETFs
- Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
- Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
- New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
- Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
- FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
- VanEck Launches Robotics ETF (IBOT)
- US Judge Weighs Nationwide Ban On Abortion Pills
Latest NHF
- NexPoint Extends Offer to Purchase Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)
- NexPoint Extends Offer to Purchase Up to All Shares of United Development Funding IV (UDFI)